ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,514.00
      1.00%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      0.00%
      Bitcoin
      67,426.33
      -0.55%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Edgewise Therapeutics Inc (EWTX)

      7. Edgewise Therapeutics Inc (EWTX) Financials

      Edgewise Therapeutics Inc

      Edgewise Therapeutics Inc (EWTX)

      NASDAQ
      18.98
      0.25
      (1.33%)
      Closed July 28 4:00PM
      Delayed by 15 minutes
      19.28
      0.30
      (1.58%)
      After Hours: 5:34PM
      Delayed by 15 minutes

      Edgewise Therapeutics Inc Financial Summary

      The current EWTX market cap is 1.8B. The company's latest EPS is USD -1.0724 and P/E is -17.69.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -25.7M-25.34M-29.45M-33.86M-34.75M
      Net Income -22.84M-21.47M-25.71M-30.14M-28.53M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -9.92M-17.19M-43.22M-71.66M-114.36M
      Net Income -9.71M-17.12M-42.81M-67.64M-100.16M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 346.4M330.63M311.36M340.04M553.81M
      Total Liabilities 17.56M19.17M20.94M21.21M18.87M
      Total Equity 328.84M311.46M290.43M318.83M534.94M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 24.54M131.14M285.23M367.1M340.04M
      Total Liabilities 1.13M4.34M10.85M20.39M21.21M
      Total Equity -16.85M-33.42M274.38M346.72M318.83M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -22.83M-43.06M-65.12M-91.95M-28.6M
      Investing 49.04M52.48M75.9M102.89M-268.31M
      Financing 21k390k179k53.17M241.07M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -9.17M-14.63M-33.51M-52.64M-91.95M
      Investing -180k-24.38M-242.23M-70.58M102.89M
      Financing 24.8M120.28M186.38M129.64M53.17M

      Stats and Ratios

      Market Cap 1.8B
      Price to Earnings Ratio -17.69
      Price to Sales Ratio 0
      Price to Cash Ratio 20.58
      Price to Book Ratio 5.56
      Dividend Yield -

      Share Statistics

      Shares Outstanding 93.4M
      Average Volume (1 week) 937.93k
      Average Volume (1 Month) 856.5k
      52 Week Change 175.82%
      52 Week High 23.50
      52 Week Low 5.12
      Spread (Intraday) 6.05 (24.55%)

      Company Info

      Company Name Edgewise Therapeutics Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://www.edgewisetx.com
      Industry pharmaceutical preparations (2834)